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Sewage surveillance in seven Italian cities between 2005 and 2008, after the introduction of inactivated poliovirus vaccination
(IPV) in 2002, showed rare polioviruses, none that were wild-type or circulating vaccine-derived poliovirus (cVDPV), andmany
other enteroviruses among 1,392 samples analyzed. Two of five polioviruses (PV) detected were Sabin-like PV2 and three PV3,
based on enzyme-linked immunosorbent assay (ELISA) and PCR results. Neurovirulence-related mutations were found in the 5=
noncoding region (5=NCR) of all strains and, for a PV2, also in VP1 region 143 (Ile> Thr). Intertypic recombination in the 3D
region was detected in a second PV2 (Sabin 2/Sabin 1) and a PV3 (Sabin 3/Sabin 2). The lowmutation rate in VP1 for all PVs sug-
gests limited interhuman virus passages, consistent with efficient polio immunization in Italy. Nonetheless, these findings high-
light the risk of wild or Sabin poliovirus reintroduction from abroad. Non-polio enteroviruses (NPEVs) were detected, 448 of
which were coxsackievirus B (CVB) and 294 of which were echoviruses (Echo). Fifty-six NPEVs failing serological typing were
characterized by sequencing the VP1 region (nucleotides [nt] 2628 to 2976). A total of 448 CVB and 294 Echo strains were identi-
fied; among those strains, CVB2, CVB5, and Echo 11 predominated. Environmental CVB5 and CVB2 strains from this study
showed high sequence identity with GenBank global strains. The high similarity between environmental NPEVs and clinical
strains from the same areas of Italy and the same periods indicates that environmental strains reflect the viruses circulating in
the population and highlights the potential risk of inefficient wastewater treatments. This study confirmed that sewage surveil-
lance can be more sensitive than acute flaccid paralysis (AFP) surveillance in monitoring silent poliovirus circulation in the pop-
ulation as well as the suitability of molecular approaches to enterovirus typing.
In 1999, a mixed polio vaccination schedule consisting of twodoses each of inactivated polio vaccines (IPV) and oral polio
vaccines (OPV)was adopted in Italy, passing to a full IPV schedule
in August 2002. Polio immunization is mandatory and free of
charge, and the nationwide vaccination coverage with 3 IPV doses
among children less than 2 years of age is 96.5% (1).
In line with the WHO eradication control requirements (2, 3,
4), a surveillance program of acute flaccid paralysis (AFP) coordi-
nated by the Italian Ministry of Health (MoH) and the Istituto
Superiore di Sanità (ISS) has been active since 1997 (5, 6, 7), and
both epidemiological and virological data indicate that Italy is free
of polio. The last poliomyelitis case due to indigenous wild virus
occurred in 1982, and the last imported wild polio case was a
poliomyelitis patient from Libya, hosted in Italy for specific med-
ical treatment in 1988 (8). In addition, no vaccine-associated par-
alytic poliomyelitis (VAPP) case has been recorded since the IPV
introduction.
During the last years, the WHO AFP indicators (9) confirmed
high performance of the Italian nationwide surveillance but re-
vealed weakness at the regional level, which probably reflects the
lower priority given by local public health systems to AFP than to
other infectious diseases.
In contrast, due to high levels of immigration across the Med-
iterranean sea, Italy remains at risk of importing wild poliovirus
(PV) from areas of endemicity as well as Sabin and neurovirulent
Sabin-derived poliovirus (circulating vaccine-derived poliovirus
[cVDPV]) from countries currently using OPV. Because the IPV
vaccine does not elicit a consistent mucosal immunity (10), silent
transmission of neurovirulent poliovirus might in fact occur
through IPV-immunized individuals, favoring possible infection
of unvaccinated subjects or children receiving delayed IPV vacci-
nation (11, 12).
In addition to virological investigation of AFP patients, several
countries also survey the circulation of wild or Sabin-derived po-
lioviruses by analysis of surfacewaters and sewage samples (13, 14,
15). As poliovirus is shed from infected subjects both with and
without paralysis, environmental poliovirus surveillance is
thought to allow sampling the entire population (13, 14, 16, 17, 18,
19). In Italy, screening of inlet sewage was initiated in 2005, tar-
Received 21 January 2014 Accepted 5 May 2014
Published ahead of print 9 May 2014
Editor: K. E. Wommack
Address correspondence to L. Fiore, lucia.fiore@iss.it.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.
doi:10.1128/AEM.00108-14
August 2014 Volume 80 Number 15 Applied and Environmental Microbiology p. 4491–4501 aem.asm.org 4491
 o
n
 January 14, 2016 by PRO
FESSO
R O
F RESEARCH
http://aem
.asm
.org/
D
ow
nloaded from
 
geting densely populated cities with high immigration rates and
AFP surveillance indicators below average.
In addition to poliovirus, coxsackievirus (CV), echovirus
(Echo), and other enteroviruses (EV) also represent a relevant
public health problem in industrialized countries, causing severe
diseases that may particularly affect young subjects and that can
occur as outbreaks, including meningoencephalitis, myocarditis
and pancreatitis, foot and mouth disease, and febrile illness (20,
21, 22, 23, 24).
Because of the different syndromes related to EV, case surveil-
lance is more difficult, and environmental monitoring can have a
major role in detecting the circulation of these viruses in the pop-
ulation and in assessing the risk for citizens. Human EVs (HEV)
have been recovered in wastewater, river, sea, and recreational
waters (25), which may represent efficient vehicles for viral trans-
mission to humans (26). Crop irrigation with treated wastewaters
is also common (27, 28, 29), and vegetables or fruits contaminated
with viruses contained in sewage are a threat for the consumer. In
fact, data from environmental monitoring and the increasing at-
tention paid to water-transmitted diseases have driven technolog-
ical improvement in wastewater treatment protocols (30, 31).
Data on the distribution of specific EV serotypes in sewage in
Italy are currently limited (32, 33, 34).
This study was conducted to investigate the poliovirus strains
possibly circulating in Italy between January 2005 and December
2008, in particular, to confirm the absence of imported wild-type
PVs after the OPV abrogation in 2002. To address this aim, all PV
strains isolated from sewage were characterized in detail by se-
quence analysis of four genomic regions, together with targeting
possible reverted neurovirulent and recombinant strains. In addi-
tion to PV, analyses also included the serological and molecular
characterization of the HEV serotypes detected in 1,392 sewage
samples collected from the wastewater treatment plants
(WWTPs) of 7 cities located in different regions. Non-polio en-
terovirus (NPEV) strains were characterized by WHO seroneu-
tralization testing, nested PCR analysis, and partial genome se-
quencing.
MATERIALS AND METHODS
Wastewater sampling. Environmental surveillance was started in 3 cities
(Rome, Milan, and Parma) in January 2005 and was extended to Bari,
Palermo, and Sassari betweenApril andMay. Finally, Naples was included
in May 2006. Sewage samples were collected at the WWTP inlet from the
collector sewers serving the surveyed urban areas.
Samples from Palermo, Sassari, and Naples were processed and ana-
lyzed in the WHO Regional Reference Laboratory (RRL) at the ISS. Sam-
ples from Rome, Parma, and Milan were examined at the accredited sub-
national polio reference laboratories: the Department of Public Health,
University of Rome La Sapienza, the Institute of Hygiene, University of
Parma, and the Institute of Virology, University of Milan, respectively.
Characterization of all poliovirus strains and typing ofmost of the NPEVs
were performed at the ISS.
The number and volume of samples representative for each popula-
tion were defined according to theWHO guidelines (35). One sample per
monthwas usually taken fromWWTPs serving fewer than 100,000 inhab-
itants and two or more samples per month from WWTPs serving
100,000 inhabitants (Table 1). Occasionally, fewer samples were col-
lected due to logistical problems, whereas extra sewage samples were col-
lected in Palermo, where particular concern was raised by the high flow of
migrants from areas of polio endemicity.
Samples (1 liter) of raw sewagewere collected during the peak hours of
household sewage flow or during 24 h for plants with an automated flow
system (Bolzano; Acqua dei Corsari and Fondo Verde, Palermo; Cuma
and Napoli Est, Naples).
Sewage and virus concentration. Sewage was collected in sterile poly-
propylene bottles and stored at 20°C usually for 3 days, until trans-
portation to the reference laboratories in dry ice or under refrigerated
conditions. Samples (500 ml each) were concentrated by the two-phase
polyethylene glycol (PEG)-dextran separation method and decontami-
nated by chloroform extraction, as recommended by theWHO(35). After
treatment, 10 ml of sample was obtained, resulting in an approximately
50-fold volume reduction.
Validation of virus concentration from wastewater. To evaluate the
virus detection capability of the WHO concentration procedure, six Pal-
ermo raw sewage samples (500 ml each) were autoclaved (121°C for 30
min) to inactivate any virus possibly present. Five samples were spiked
with 2  105, 2  103, 20, 2, and 0.2 50% cell culture infective doses
(CCID50) of poliovirus type 1 Sabin, respectively, and a sixth sample
served as a negative control (35). Wastewaters were concentrated as de-
scribed above, and 10 ml was obtained for both spiked and control sam-
ples. A 0.5-ml volume of chloroform-extracted sewage concentrate was
inoculated onto RD cell monolayers in 50-ml cell culture flasks, in dupli-
cate. Two serial blind passages were performed in the event of a negative
first-passage result.
Clinical samples. Cerebrospinal fluid samples (CSF) were collected
from four patients involved in an outbreak of meningitis that occurred in
Sassari in December 2005. Stools from a 4-year-old female presenting
with Guillain-Barré syndrome reported in Sassari in December 2008 were
processed according to guidelines of the polio laboratory manual (36).
TABLE 1 Sampling per year for each collector and city during
environmental surveillance in Italy (2005 to 2008)
City
Collector
sewer
locationa
No. of
inhabitants in
catchment area
No. of samples
2005 2006 2007 2008 Total
Milan MN 300,000 18 17 23 24 82
MNE 300,000 18 17 23 24 82
MP 300,000 NDb 17 22 24 63
Parma PE 130,000 22 24 22 24 92
PO 160,000 22 24 22 24 92
Rome RN 490,000 18 15 12 0 45
RE 720,000 22 15 12 0 49
RS 1,000,000 24 17 14 0 55
Bari BF 300,000 18 24 23 24 89
MB 300,000 18 24 23 24 89
BJ 300,000 18 20 23 24 85
Palermo AdC 130,000 14 24 35 24 97
FV 70,000 14 20 24 24 82
VD 70,000 6 10 12 12 40
JH 70,000 7 10 11 11 39
Naples NC 1,000,000 ND 34 44 9 87
NT 700,000 ND 30 30 20 80
NE 500,000 ND 23 29 20 72
Sassari SS 120,000 12 24 24 12 72
All 251 389 428 324 1392
a MN, Milan Nosedo; MNE, Milan Nosedo Est; MP, Milan Peschiera; PE, Parma Est;
PO, Parma Ovest; RN, Rome Nord; RE, Rome Est; RS, Rome Sud; BF, Bari Fesca; MB,
Mola di Bari; BJ, Bari Japigia; AdC, Acqua dei Corsari; FV, Fondo Verde; VD, Via Diaz;
JH, Jolly Hotel; NC, Naples Cuma; NT, Naples Teduccio; NE, Naples Est; SS, Sassari.
b ND, sampling not done.
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Cell cultures and virus isolation. Virus isolation was performed ac-
cording to the WHO guidelines for clinical fecal specimens (36), inocu-
lating 0.5 ml of the 10-ml chloroform-extracted sewage concentrate onto
twoRDand twoL20B (selective for polioviruses) cellmonolayers in 50-ml
cell culture flasks. Two serial blind passages were performedwith both cell
lines, and samples positive on RD cells were passaged on L20B for specific
amplification of poliovirus.
Identification and characterization of viruses. For rapid virus iden-
tification, cytopathic effect (CPE)-positive cell lysates were tested by PCR
with primers (PVM1-1 [5=CAA GCA CTT CTG TTT CCC C3=] and
PVM1-2 [5=ATT GTC ACC ATA AGC AGC CA3=]) specific for the 5=
noncoding region [5=NCR]) (nucleotide [nt] 179 to 575) (37) common to
all enteroviruses.
Samples inducing CPE but with negative enterovirus PCR results were
classified as enteric nonenteroviruses (ENEV) and were not investigated
further.
Immunostaining of infected cells withmonoclonal antibodies (MAbs)
specific for each poliovirus serotype, coxsackievirus B1 to B6, echoviruses
4, 6, 9, 11, 30, and 34 (Chemicon International, Temecula, CA), and a
pan-enterovirus MAb (Dako, Denmark) was also used for confirmation
(38). Virus typing was performed by microneutralization assays using EV
serum pools and type-specific poliovirus antisera (RIVM, Bilthoven). In-
tratypic differentiation of Sabin-like (SL) polioviruses from non-Sabin-
like (NSL) polioviruses was performed by enzyme-linked immunosor-
bent assays (ELISA) using cross-adsorbed antibodies (RIVM) and by
reverse transcription-PCR (RT-PCR) with specific primers (CDC) (36).
Sequencing of the 5=NCR (nt 179 to 575), VP1 (nt 2482 to 3384 for PV2
and nt 2477 to 3376 for PV3), VP1/2A junction (nt 3241 to 3460), and 3D
(nt 6086 to 6376) genomic regions following RT-PCR amplification was
also performed for all poliovirus isolates (37, 39). The 5=NCR was also
sequenced to confirm the typing of some coxsackievirus and echovirus
strains using the primers described above (40, 41).
Sewage EV isolates classified as untypeable by neutralization assays
were typed by nucleotide sequencing of the amplicon resulting from a
seminested RT-PCR analysis of the VP1 region, including the BC loop (nt
2628 to 2976) encoding a linear antigenic site (42). Sequencing was per-
formed by Macrogen (Korea), using primers AN88 (5=TAC TGG ACC
ACC TGG NGG NAY RWA CAT3=) and AN89 (5=CCA GCA CTG ACA
GCA GYN GAR AYN GG3=).
The sequences of the VP1 region amplified from HEV isolates were
analyzed using the neighbor-joining (NJ) method for clustering. The per-
centage of identity was determined based on the number of nucleotide
substitutions per site. The alignment of sequences was performed using
Mega 5.0 software (43). Amino acid sequence alignments were obtained
using BioEdit software (44).
Nucleotide sequence accession numbers. The nucleotide sequences
of the 5=NCR, VP1, VP1/2A junction, and 3D regions of polioviruses
(Table 2) have been deposited in the GenBank database under accession
numbers KJ852629 to KJ852648; those of coxsackieviruses B2 and B5
(Figures 2, 3, and 4) have been deposited under accession numbers
KJ867446 to KJ867452 and KJ867453 to KJ867459, respectively.
RESULTS
Virus recovery and detection limit. Sewage samples spiked with
2 105 and 2 103CCID50 of Sabin type 1 poliovirus suspension,
respectively, produced a CPE upon passage of the first RD cells,
while CPE was seen only on the second passage using 20 CCID50 of
virus.Thesample spikedwith2CCID50ofSabin type1polioviruswas
CPEnegative.The resultingdetection limit of 20CCID50/sample is in
line with the WHO requirements for a satisfactory environmental
surveillance of poliovirus and other enteroviruses (35).
Identification of enteroviruses in sewage samples. Between
January 2005 and December 2008, 1,392 sewage samples were
collected from 19WWTPs in seven cities and analyzed for entero-
viruses (Table 1).
Overall, 702 samples gave CPE-positive results in cell cultures,
ranging from41%of 104 samples in 2005 to 56%of 181 samples in
2008. In 680 (96.8%) cases, the enterovirus positivity in cell cul-
tures was confirmed by RT-PCR with 5=NCR-specific primers.
Twenty-two samples that induced CPE in RD cells gave nega-
tive results by 5=NCR PCR with primers specific for enteroviruses
and were classified as positive for enteric nonenteroviruses
(ENEV). These viruses were not investigated further andmay pos-
sibly have contained norovirus, rotavirus, or other enteric viruses.
Of the 680 enterovirus-positive samples, 612 contained one virus
and 68 contained two viruses, yielding a total of 748 enterovirus
strains. Seroneutralization tests (RIVM polyclonal sera) identified 5
(0.7%) polioviruses, 415 (55.5%) coxsackievirus B strains, 1 (0.1%)
coxsackievirus A strains, 271 (36.2%) echoviruses, and 56 (7.5%)
untypeable enteroviruses (NTEVs). After seminested PCR and se-
quencing, the latter were found to be common enteroviruses, i.e.,
coxsackievirus B2 (CVB2) (13 samples), CVB3 (9), CVB5 (6), CVB1
(3), CVB4 (2), Echo 11 (8), Echo 6 (5), Echo 13 (4), Echo 7 (3), Echo
19 (1), Echo 25 (1), and Echo 30 (1). Therefore, overall CVB and
echovirus totals were 448 and 294, respectively.
Five polioviruses were isolated in four different cities in 2005,
TABLE 2 Polioviruses isolated in sewage samples during the surveillance in Italy (2005 to 2008)a
Cities Date Serotype ITD
Sequence
5=NCR VP1 VP1/2A 3D
Parma June 2005 PV3 SL 472 U C
Naples May 2007 PV3 SL 472 U C
473 C U
Milan September 2007 PV2 SL 481 A G 2487 T C Recombinant S2/S1
2736 T C
Milan April 2008 PV2 SL 325 U C 2909 T C 6147 T C
481 A G 6213 G A
6285 C T
Palermo June 2008 PV3 SL 472 U C 2637 C T Recombinant S3/S2
a 5=NCR, nt 179 to 575; VP1, nt 2482 to 3384 for PV2 and nt 2477 to 3376 for PV3; VP1/2A, nt 3241 to 3460; 3D, nt 6086 to 6376. ITD, intratypic differentiation.
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2007, and 2008 (Table 2) and were characterized as three Sabin-
like poliovirus 3 and two Sabin-like poliovirus 2 strains by both
ELISA (RIVM) and PCR (CDC) tests (36). Their genomes were
sequenced and compared with the sequences of PV reference
strains (AY184219.1, AY184220.1, and AY184221.1 [accession
numbers for PV1, PV2, and PV3, respectively]) (Table 2). Inter-
estingly, all strains contained a 472 (U C) mutation or a 481 (A
 G) mutation, which have been associated with reversion to the
neurovirulent phenotype in PV3 and PV2, respectively. Addi-
tional mutations were found in the same region, specifically, at nt
473 (C  U) in strain Naples 07 and at nt 325 (U  C) in strain
Milan 08. Mutations in the region coding for VP1 (nt 2482 to
3384) were identified only in strain Milan 07, at nt 2487 (T C)
and at nt 2736 (TC), in strainMilan 08, at nt 2909 (TC), and
in strain Palermo 08, at nt 2637 (C  T). Mutation in VP1 at nt
position 2909 of PV2 Milan 08 induced an amino acid substitu-
tion (I143T), confirming the fully neurovirulent genotype of this
strain. Interestingly, poliovirus isolates PV2 Milan 07 and PV3
Palermo 08 also showed intertypic recombination with other PV
serotypes in the region encoding the 3Dpolymerase (pol) (nt 6086
to 6376) (Table 2): PV2 strain Milan 07 presented a Sabin 1 se-
quence between nt 6354 to 6109, and PV3 strain Palermo 08
shared nt 6354 to 6109 (typical of Sabin 2). The crossing-over site
for isolate Milan 07 was at nt 6230. In PV2 strain Milan 08, three
additional mutations were also present in the region encoding the
3D pol, at nt 6147 (T C), 6213 (G A), and 6285 (C T). All
mutations present in the VP1, except nt 2909 (T  C) in PV2
strainMilan 08, and in the 3D regionswere synonymous, inducing
no amino acid change.
Among the 13 different echovirus serotypes isolated, Echo 11
(32.7%) and Echo 6 (37.1%) largely predominated, followed by
Echo 4 (16.7%), whereas the proportions of the other serotypes
ranged between 0.3% to 3.7%of cases (Table 3). Among coxsacki-
eviruses, serotypes CVB5 and CVB3 were more frequent (both
29.9%), followed by CVB4 (20.0%), CVB2 (15.8%), and CVB1
(4.2%) (Table 3), whereas CVB6 was not isolated in this study.
Type A coxsackieviruses were detected very rarely (0.2%); specif-
ically, only serotype CVA24 was detected.
The enteroviruses identified in the different cities investigated
are reported in Table 3. Major differences were shown in the EV
serotypes predominating between different cities.
The monthly distribution of enteroviruses isolated during the
study period in northern, central, and southern Italy is shown in
Fig. 1. With few exceptions, both the CVBs and echoviruses were
TABLE 3 Distribution by city of enteroviruses isolated from sewage
samples in Italy (2005 to 2008)
EV
serotypea
No. of samples by region and city
North
(n 273)
Central
(n 113)
South
(n 362)
TotalMilan Parma Rome Sassari Naples Palermo Bari
CAV 24 0 0 0 0 0 0 1 1
CVB 1 2 1 3 2 1 0 10 19
CVB 2 10 18 7 2 7 8 19 70
CVB 3 10 27 4 4 25 37 27 134
CVB 4 1 30 4 13 30 5 8 90
CVB 5 22 32 27 15 8 20 10 134
Echo 3 1 0 0 0 0 2 1 4
Echo 4 12 2 0 16 6 2 11 49
Echo 6 67 0 0 1 9 6 13 96
Echo 7 5 0 0 0 0 4 0 9
Echo 9 1 0 0 0 1 0 0 2
Echo 11 15 0 0 13 36 11 34 110
Echo 12 0 0 0 0 0 1 0 1
Echo 13 8 0 0 0 2 1 0 11
Echo 19 1 0 0 0 0 0 0 1
Echo 22 1 0 0 0 0 0 0 1
Echo 25 1 0 0 0 1 0 0 2
Echo 29 1 0 0 0 0 0 0 1
Echo 30 1 1 0 2 0 3 1 8
PV 2 1 0 0 1 0 1 5
Total 161 112 45 68 127 100 135 748
a CAV, coxsackievirus A; CVB, coxsackievirus B; Echo, echovirus; PV, poliovirus.
FIG 1 Percentages of geographic and seasonal distribution of enteroviruses
isolated in RD cell cultures during monthly routine environmental surveil-
lance in northern (Milan and Parma) (A), central (Rome and Sassari) (B), and
southern (Bari, Naples, and Palermo) (C) Italy in 2005 to 2008.
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detected in allmonths, with a prevalence of CVBs compared to the
echoviruses, a trend which did not differ with respect to geo-
graphic areas. For CVBs, peaks were observed in themonths from
May to August and October to November, whereas for the echo-
virus, peaks appeared between August and September and were
more pronounced in the northern and central regions than in the
southern regions. Polioviruses were detected only between April
and September.
VP1 amino acid sequence analysis of selected CVB5 and
CVB2 strains. The 56 enteroviruses that could not be typed with
the RIVM antibodies were subjected to partial sequencing of the
VP1 region, including the BC loop, to investigate possible amino
acid changes responsible for the lack of neutralization. Of these,
four randomly selected CVB5 and five CVB2 strains were com-
pared with other CVB5 and CVB2 strains serotyped in this study
andwith reference andGenBank strains (Fig. 2 and 3). All test and
GenBankCVB5 strains showed identical sequences in this genome
region, except for a T119I amino acid change in a single strain.
Three further changes (Y91Q, T125S, and Q132K) were shown by
all strains compared to the Faulkner reference strain (Fig. 2).
Comparative amino acid sequence analysis of coxsackievirus
B2 also showed the same substitution (R54H) for all field strains
with respect to the reference Ohio-1 strain. One of the serologi-
cally untypeable CVB2 strains presented no further changes,
whereas three other strains showed two (K99R and H119E) and
another strain three (E117D, G118I, and H119E) additional
changes (Fig. 3). In contrast, the two normally serotyped CVB2
strains investigated presented one or two amino acid changes
(T84N or T84N and T86A, respectively). The former change was
also presented by three GenBank strains of different origins
(Fig. 3).
Phylogenetic analysis of CVB5 and CVB2 strains. Phyloge-
netic analysis of the VP1 gene sequence of randomly selected
CVB5 isolates, classified as typeable or untypeable by serological
tests in this study, and 11 CVB5 strains isolated in different years
and countries, available in GenBank, was carried out. All Italian
strains showed high sequence similarity (99%), grouped with the
other global strains within the same cluster, andwere distant from
the Faulkner reference strain, which presented only 82% identity
with field CVB5 isolates (Fig. 4A).
FIG 2 Coxsackievirus B5multiple amino acid alignments (amino acids [aa] 60 to 138) of theVP1 partial structural protein of sequences of the Faulkner reference
strain, seven Italian strains, four untypeable strains (marked by a circle), and three typeable strains (marked by a triangle) and 11 others isolated in different areas
in the world and available on GenBank. (Each dot indicates a position where there was no difference in sequence from the reference strain).
FIG 3 Coxsackievirus B2 multiple amino acid alignments (aa 53 to 121) of the VP1 partial structural protein of sequences of the Ohio-1 reference strain, seven
Italian strains, five untypeable strains (marked by a circle), and two typeable strains (marked by a triangle) and 11 others isolated in the different areas of theworld
and available on GenBank. (Each dot indicates a position where there was no difference in sequence from the reference strain).
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In contrast, the two Italian serotyped CVB2 strains analyzed
shared high sequence similarity between themselves (97%) and
with the Ohio-1 reference strain, whereas the five strains proving
untypeable by serological tests shared lower nucleotide similarity
(92%) with the former strains, grouping within a separate cluster.
However, all CVB2 strains from this study clustered with other
CVB2 strains reported in different countries during the same pe-
riod (Fig. 4B).
FIG 4 Neighbor-joining phylogenetic tree of the partial nucleotide sequence encoding the VP1 region (nt 2628 to 2976) of coxsackievirus B5 and B2 isolated
from environmental surveillance in Italy between 2005 and 2008. (A) Coxsackievirus B5 strains: four serologically untypeable strains (circles), three typeable
strains (triangles) identified in this study, and other reference or field strains. (B) Coxsackievirus B2 strains: five serologically untypeable strains (circles), two
typeable strains (triangles) identified in this study, and other reference and field strains. GenBank accession numbers are reported. The evolutionary history was
analyzed using the neighbor-joining algorithm in the Mega 5 program, with the Kimura-2 parameter. The scale bar indicates the number of nucleotide
substitutions per site. Bootstrap values in 1,000 pseudoreplicates75 are indicated at the branch nodes.
Battistone et al.
4496 aem.asm.org Applied and Environmental Microbiology
 o
n
 January 14, 2016 by PRO
FESSO
R O
F RESEARCH
http://aem
.asm
.org/
D
ow
nloaded from
 
Enteroviruses from clinical cases in Italy. An Echo 30 strain
was isolated from the spinal fluid collected from four patients
during an outbreak of meningitis that occurred in Sassari in De-
cember 2005 (Table 4). In December 2008, a coxsackievirus B5
strain was isolated in this same city from two stool samples from
an AFP case presenting with Guillain-Barré syndrome (Table 4).
The 5=NCR (nt 179 to 575) and VP1 (nt 2628 to 2976) sequences
of these strains were compared with those of Echo 30 strains iso-
lated from environmental samples in Sassari in October and No-
vember 2005 and with that of a CVB5 strain isolated in December
2008. Three Echo 30 strains from meningitis cases showed 100%
identity in both the 5=NCR and VP1 with the Echo 30 strain iso-
lated from wastewater few days later. The isolate from the fourth
patient showed 100% nucleotide similarity in the 5=NCR and
99.4% in VP1. The CVB5 strains had 100% similarity in both the
5=NCR and VP1 with the CVB5 environmental isolate.
DISCUSSION
In recent years, several studies investigating viral pollution in sur-
face waters have been carried out on both river and coastal waters
of Italy (45, 46, 47, 48, 49, 50, 51). In contrast, only a few recent
investigations have been performed using detailed serotyping of
enterovirus strains in Italian wastewaters (32, 33, 34, 52) com-
pared to a higher number of similar studies reported from other
countries (53, 54, 55, 56, 57, 58).
This study was undertaken as a supplement to the AFP surveil-
lance in Italy tomonitor the possible presence of wild-type (WPV)
or vaccine-derived (cVDPV) poliovirus or other enterovirus
strains in wastewaters and to obtain further evidence in support of
the maintenance of the polio-free status of Italy.
For this purpose, a network of laboratories using standardized
methods for sample collection and virus isolation was established.
No wild polioviruses were isolated from the environmental
samples examined during the study period, supporting the epide-
miological data deriving from AFP surveillance (6, 7, 59).
The isolation of 5 Sabin-like polioviruses demonstrated that
environmental surveillance is an effective supplemental support
to the AFP surveillance to verify the absence of wild or cVDPV
neurovirulent polioviruses in circulation in the country. In fact,
since the introduction of IPV vaccination in 2002, no polioviruses
have been isolated from the AFP cases notified in Italy, whereas
environmental surveillance was able to detect the presence of
Sabin-like polioviruses, although rarely. The low degree of muta-
tion found in the genomes of the 5 Sabin-like polioviruses isolated
suggests that these viruses have undergone only limited circula-
tion in the population, which implies the effectiveness of polio
immunization and a high level of protection against polio in Italy.
Since the use of vaccination with poliovirus Sabin vaccine in
Italywas dismissed in 2002, the poliovirus Sabin-like strains found
in the environment have most likely been excreted by children
immunized with OPV abroad or by contacts of vaccinees and
should thus be considered imported viruses. Italy has in fact ex-
perienced a high rate of immigration during the last 10 years.
Nevertheless, the presence of Sabin-like revertant poliovirus
strains with mutations associated with neurovirulence in the en-
vironment may represent a risk of disease for both unvaccinated
subjects and immunodeficient patients. In Italy, some delay in the
administration of the first dose of IPV has been reported in some
regions, although rarely. Moreover, although vaccination is man-
datory in Italy, some parents refuse vaccination for their children
because of prejudice or religious problems even if this implies
losing access to public education. Poliovirus might therefore rep-
licate unnoticed in immunodeficient subjects andmight be trans-
mitted to contact persons if they are unvaccinated.
The presence of intertypic recombination in the 3D region of
the poliovirus isolated in Milan and Palermo is interesting, even
though similar recombinations were previously detected in polio-
virus isolated in several other countries (41, 60, 61). Increased
transmissibility over that of Sabin parental strains has been sug-
gested to be the consequence of a recombinant event (62). The two
PV2 isolates from Milan most likely represented separate events
since the April 08 isolate lacks the recombination in the polymer-
ase 3D that was found for the earlier September 07 isolate.
Most of the polioviruses were isolated between April and June,
months when more tourists are present in Italy and immigration
increases. The lack of isolation of poliovirus type 1 Sabin-like
strains might be related to the reduced replication of this serotype
in the human gut (63, 64) or might suggest lower resistance in the
environment. In fact, PV1 was isolated from sewage with lower
frequency than other PV serotypes following introduction of IPV
vaccine in New Zealand (65).
In contrast to polioviruses, non-polio enteroviruses were de-
tected during all seasons in our study. This findings are, however,
unusual for countries with a temperate climate, where the major-
ity of enterovirus infections usually occur in summer and autumn,
and resemble the situation in tropical countries (66, 67, 68). The
large presence of non-polio enteroviruses (coxsackievirus type B
TABLE 4 Sequence comparison of enteroviruses isolated from clinical and environmental samples in Sassari in the same period and in different
years
Samplea Date (day[s]/mo/yr) Sample source Disease Virus % 5=NCR identityb % VP1 identityc
SS/105 22/12/2005 Liquor Meningitis Echo 30 100 100
SS/205 22/12/2005 Liquor Meningitis Echo 30 100 100
SS/305 22/12/2005 Liquor Meningitis Echo 30 100 100
SS/405 22/12/2005 Liquor Meningitis Echo 30 100 99.4
SS-05-09 30/10/2005 Wastewater Echo 30
SS-05-11 30/11/2005 Wastewater Echo 30
SS/505 13–14/12/2008 Stool AFP (GBS) CVB 5 100 100
SS-08-23 15/12/2008 Wastewater CVB 5
a Patients: SS/105, SS/205, SS/305, SS/405, and SS/505; SS, Sassari.
b Nucleotide identity between nucleotides 179 and 575 of 5=NCR regions in human case samples and environmental samples.
c Nucleotide identity between nucleotides 2628 and 2976 of VP1 regions in human case samples and environmental samples.
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and echoviruses) in sewage demonstrates that these viruses have a
large diffusion in the population and that they might result in
severe diseases (meningitis, encephalitis, myocarditis, etc.). The
massive environmental dissemination of these pathogens to re-
ceiving water bodies (seas, rivers, etc.) and the very low infectious
dose of most enteric viruses emphasizes the risk to public health,
considering that legal requirements for microbiological monitor-
ing of wastewaters in Italy and other European countries address
only bacterial parameters (69, 70, 71, 72, 73). According to the
WHO, the high rate of NPEV in the environment can be consid-
ered a proof that the environmental samples were processed and
analyzed appropriately and that the cold chain used during spec-
imen transportation was effective in preserving virus infectivity.
The frequencies of detection of differentNPEV species differed
in the various geographical areas and differed between years, but
overall, coxsackievirus B strains, in particular, CVB5, CVB3, and
CVB4, were isolated more often than echovirus strains. These
findings are in line with data reported from enterovirus surveil-
lances in Europe and with some studies on sewage surveillance
(56, 74, 75). CVB5 is an emerging serotype that has been corre-
lated with some outbreaks of meningitis and other diseases in the
last 10 years (76, 77, 78), but no clinical cases have been reported
in Italy or (probably) investigated by detailed serotyping. The rare
isolation of coxsackievirus A in our study might indicate low cir-
culation of these strains in the Italian population, although it
might also be related to the lower susceptibility of RD cells to
infection with CVA.
The most prevalent echoviruses were serotype 11 and 6, in
particular, in southern and northern cities, respectively. These
echoviruses are associated with childhood diseases, specifically,
meningitis, respiratory, and gastrointestinal illnesses for Echo 11,
febrile illness for Echo 4, and outbreaks of respiratory diseases for
Echo 6 (79, 80). Echovirus 30, which was the virus most com-
monly isolated during meningitis outbreaks in several countries
(81, 82, 83, 84, 85), was detected with low frequency in the present
study.
However, it should mentioned that the use of RD cells in this
study may have led to underestimation of some HEVs serotypes,
since not all HEVs can be cultivated in these cells. The use of
multiple cell lines would optimize isolation of some other entero-
viruses (86), but that benefit is counterbalanced by the increased
workload and expenses due to reagents and consumables com-
pared to those of the rapid and cheaper molecular techniques.
It should also be taken into account that there are still a num-
ber of HEV serotypes that fail to replicate on many cell cultures
(87), includingCVAofHEV-C,whose detection is very important
for the possibility of recombination with PV (88).
Sequence analysis of the serologically untypeable enteroviruses
that could be identified only by molecular methods revealed scat-
tered mutations in their genomes, which has been previously re-
ported to occur during replication in humans. Some of these mu-
tations might have affected binding of polyclonal antibodies and
strain identification by neutralization assays. In fact, some muta-
tions involved amino acid substitutions inVP1,which is one of the
outer capsid proteins containing the BC loop. However, no differ-
ences were found in the amino acid sequence in comparisons be-
tween CVB5 strains that were typeable or not typeable by neutral-
ization tests in the region sequenced, while two VP1 mutations
were identified between typeable or some untypeable CVB2
strains. An additional substitution was present at amino acid 84
within the BC loop in other CVB2 strains. However, our findings
do not allow us to confirm a possible role of these mutations in
resistance to antibody neutralization, as was previously suggested
by others (89). The BC loop is the only known linear antigenic site
in poliovirus; the other sites are conformational, and a more de-
tailed study would therefore involve the sequencing of all capsid
proteins and conformational analysis.
Mutations that possibly affect strain recognition by antibodies
may endanger enterovirus typing, and new antisera or monoclo-
nal antibodies may be needed to update serological reagent panels
from time to time. However, our data confirm that isolates failing
serological typing may be successfully investigated by molecular
techniques.
Phylogenetic analyses of the Italian CVB5 and CVB2 strains
suggest that both were highly similar to contemporary strains iso-
lated in other parts of the world available in GenBank while being
very different from the reference strains Faulkner and Ohio. The
Italian CVB2 strains that were untypeable by antibody assays were
more distantly related to the reference strain than the typeable
strains, and the distance from the tight cluster of isolates identified
most likely suggests a separate introduction and evolution of
CVB2.
Combining conventional cell culture isolation methods with
RT-PCR allowed confirmation of the presence of enterovirus ge-
nome in cells showing CPE in a few additional hours and is more
effective than direct molecular detection, particularly in cases of
low viral concentrations and/or RT-PCR inhibitors in environ-
mental samples. It should also be considered that maintaining
adequate supplies of HEV typing antibody pools for the Global
Polio Laboratory network will be difficult in the future.
Overall, the results of our study indicate that extension of
wastewater screening to other cities of Italy could be helpful both
to supplement AFP surveillance, particularly in areas with larger
immigration, and to investigate possible risks of other human dis-
eases and epidemic outbreaks correlated to non-polio enterovi-
ruses, such as enterovirus meningitis, possibly linked to water-
borne and food-borne transmission routes.
In conclusion, although AFP surveillance remains the gold
standard for poliovirus surveillance, supplemental activities can
be useful to implement a satisfactory overall surveillance perfor-
mance. From our study, sewage surveillance appears to be more
sensitive than AFP surveillance in monitoring the silent circula-
tion of poliovirus in the population in countries such as Italy
where polio clinical cases have been absent for a long time and
could be considered more generally for the posteradication era.
Finally, the systematic collection of environmental samples for
investigation of poliovirus circulation may be used conveniently
for monitoring other enteric agents such as adenovirus, rotavirus,
norovirus, and hepatitis virus.
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